GS consortium’s Hugel acquisition is close to completion Source says price adjustment is unlikely and deal will close soon
Translated by Ryu Ho-joung 공개 2022-01-20 08:12:34
이 기사는 2022년 01월 20일 08:08 thebell 에 표출된 기사입니다.
An acquisition of South Korea’s No. 1 botox maker Hugel by a consortium led by GS Group appears close to completion with no changes to the original agreement.The GS-led consortium signed a share purchase agreement to buy a controlling stake in Hugel from US buyout firm Bain Capital last summer. The transaction has not closed yet, although the deadline for the deal was January 11.
This raised speculation about potential renegotiations over a price, especially after the country’s food and drug agency ordered last November the revocation of licenses for some of the company’s botox products.
However, it appears that the GS consortium remains committed to acquiring Hugel regardless of the revocation issue.
“(The consortium) will pay the remaining acquisition costs soon,” said a source familiar with the deal. “Speculation about a potential price adjustment is not true and that’s highly unlikely.”
The GS consortium agreed to buy a 42.9% stake in Hugel for about 1.7 trillion won ($1.4 billion) in August last year. Around 1.3 trillion won of the total acquisition costs was already paid, while the balance remains to be paid.
The consortium consists of GS Group, Seoul-based private equity firm IMM Investment, Singapore-based healthcare-dedicated investment firm CBC Group and Abu Dhabi sovereign wealth fund Mubadala.
The consortium funded about 40% of the acquisition costs, or $575 million, through debt financing. Additionally, GS Group plans to pay $150 million by using its cash on hand, while IMM Investment will invest $150 million from its blind-pool fund. (Reporting by Ha-na Suh)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- '재무개선' AJ네트웍스, 조달비용 '확' 낮췄다
- '9년만에 엑시트' 한앤코, 한온시스템 거래구조 살펴보니
- 한국타이어앤테크놀로지, 한온시스템 인수한다
- [수술대 오른 커넥트웨이브]2대주주 지분매입 나선 MBK, 주식교환 카드 꺼냈다
- [이사회 모니터]이재용 에이비프로바이오 대표, 바이오·반도체 신사업 '드라이브'
- 와이투솔루션, 주인 바뀌어도 '신약' 중심엔 美 합작사 '룩사'
- 아이티센, 부산디지털자산거래소 본격 출범
- 아이에스시, AI·데이터센터 수주 증가에 '날개'
- [이사회 모니터]서정학 IBK증권 대표, ESG위원회도 참여 '영향력 확대'
- SW클라우드 '10주년' 폴라리스오피스, “초격차 밸류업”